Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948454 · ClinicalTrials.gov registry record
Research Study on the Effects of Smoking on Arteries
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 105
- Enrollment target
NCT00948454: Completed study, sponsored by University of Pennsylvania.
NCT00948454 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948454 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
The current proposal, will elucidate the role of oxidant stress (OS) on arterial function as measured by flow mediated vasodilation. In addition, the investigators will address the hypothesis, that a pro-oxidant might have different degrees of effects on different biological targets, by performing quantitative assessment of the effects of OS on lipids, proteins and DNA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2003-01 |
| Est. Completion | 2006-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00948454
The ClinicalTrials.gov registry entry for NCT00948454 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00948454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00948454 about?
NCT00948454 is a clinical study titled "Research Study on the Effects of Smoking on Arteries". The current proposal, will elucidate the role of oxidant stress (OS) on arterial function as measured by flow mediated vasodilation. In addition, the investigators will address the hypothesis, that a pro-oxidant might have different degrees of effects on different biological targets, by performing q...
What is the current status of trial NCT00948454?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2003-01. Estimated completion is 2006-06.
Who is sponsoring clinical trial NCT00948454?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.